Invention Application
- Patent Title: PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DIABETES
- Patent Title (中): 用于治疗糖尿病的药物组合物
-
Application No.: US14928409Application Date: 2015-10-30
-
Publication No.: US20160046592A1Publication Date: 2016-02-18
- Inventor: Kayo MATSUMOTO , Wataru MIYANAGA , Mizuki DOHI , Tadakiyo NAKAGAWA , Kaori KOBAYASHI , Sen TAKESHITA
- Applicant: Ajinomoto Co., Inc.
- Applicant Address: JP Tokyo
- Assignee: Ajinomoto Co., Inc.
- Current Assignee: Ajinomoto Co., Inc.
- Current Assignee Address: JP Tokyo
- Priority: JP2013-096535 20130501
- Main IPC: C07D307/79
- IPC: C07D307/79 ; C07D207/16 ; C07C323/18 ; C07D239/26 ; C07D213/40 ; C07D207/06 ; C07D211/98 ; C07D263/32 ; C07D405/12 ; C07D407/12

Abstract:
An object is to provide a novel compound which has a glycogen synthase activation ability, but activates a receptor PPAR to a low degree and is highly safe. Provided is a compound represented by the following general formula (I) or a pharmaceutically acceptable salt thereof: wherein Ar1 represents any one of the following rings (II) and (III): wherein R2 represents an alkyl group, and R3 represents a hydrogen atom or an alkyl group, and R1 represents any one of the following substituents (IV) and (V):
Information query